Authors
Loading...
Retrospective analysis demonstrates median survival of 19 months in glioblastoma patients, suggesting enhanced outcomes in specialized neuro-oncology care.
Pickles et al. (2025) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: